Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial-Reference-Cited by-同舟云学术

Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial

Published:2021-05-31 Issue:6 Volume:20 Page:743-751
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Feng Yongliang¹²,Yao Tian¹²,Han Yujie¹²,Shi Jing¹²,Dong Shuang¹²,Wu Yuanting¹²,Shao Zhihong¹,Liu Hongting³,Guo Hongping⁴,Chai Guowei⁵,Liu Liming⁶,Wang Fuzhen⁷,Wang Jianmin²⁶,Liang Xiaofeng⁸,Wang Suping¹²

Affiliation:

1. School of Public Health, Shanxi Medical University, Taiyuan, China

2. Center of Clinical Epidemiology and Evidence Based Medicine, Shanxi Medical University, Taiyuan, China

3. Department of nephrology, Yuncheng Central Hospital, Yuncheng, China

4. Department of nephrology, Linfen People’s Hospital, Linfen, China

5. Department of nephrology, Houma People’s Hospital, Houma, China

6. Department of nephrology, Linfen Central Hospital, Linfen, China

7. National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China

8. Chinese Preventive Medicine Association, Beijing, China

Funder

Ministry of Science and Technology of China

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14760584.2021.1915777

Reference34 articles.

1. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

2. NBSPRC. [Internet]. Beijing (BJ): China Statistical Publishing House; 2019, September. Available from: http://www.stats.gov.cn/tjsj/ndsj/2019/indexch.htm

3. Economic burden of chronic kidney disease in Korea using national sample cohort

4. Economic Burden of ESRD to the Malaysian Health Care System

5. Immune Dysfunction and Risk of Infection in Chronic Kidney Disease

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between vaccine dose and risk of hepatitis B virus infection in Fujian Province, China;Human Vaccines & Immunotherapeutics;2022-12-15

2. Duration of immunogenicity of high-dose and prolonged-schedule hepatitis B vaccine among patients with chronic kidney disease: A one year follow-up study in China;Expert Review of Vaccines;2022-08-18